世界の血友病治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Hemophilia Therapeutics Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z2772 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥553,800 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥830,700 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,107,600 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、血友病治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（血友病A、血友病B、血友病C）、用途別市場規模（病院、クリニック、外来手術センター）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・血友病治療の市場動向 ・企業の競争状況、市場シェア ・血友病治療の種類別市場規模（血友病A、血友病B、血友病C） ・血友病治療の用途別市場規模（病院、クリニック、外来手術センター） ・血友病治療の北米市場規模2016-2027（アメリカ、カナダ） ・血友病治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・血友病治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・血友病治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・血友病治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Bayer AG、Pfizer, Inc.、Novo Nordisk A/S、Baxter International Inc.、Biogen Idec, Inc.、Genetics Institute、Alpha Therapeutics Corporation、Expression Therapeutics、Swedish Orphan Biovitrum AB.） ・結論

Hemophilia is a rare, inherited disorder in which blood doesn’t clot normally due to the lack of sufficient blood clotting factor. Clotting factor is a protein required for blood clotting to occur normally. These proteins work with platelets i.e. small blood cell fragments that form in the bone marrow, to help the blood clot. Hemophilia is passed from parents to children through genes.

Market Analysis and Insights: Global Hemophilia Therapeutics Market
The global Hemophilia Therapeutics market size is projected to reach US$ 13440 million by 2026, from US$ 9481.5 million in 2019, at a CAGR of 5.1% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Hemophilia Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Hemophilia Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Hemophilia Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Hemophilia Therapeutics market.

Global Hemophilia Therapeutics Scope and Market Size
Hemophilia Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Hemophilia Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
hemophilia A
hemophilia B
hemophilia C

Segment by Application
Hospitals
Clinics
AmbulatorySurgicalCenters

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Bayer AG
Pfizer, Inc.
Novo Nordisk A/S
Baxter International Inc.
Biogen Idec, Inc.
Genetics Institute
Alpha Therapeutics Corporation
Expression Therapeutics
Swedish Orphan Biovitrum AB.

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hemophilia Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 hemophilia A
1.2.3 hemophilia B
1.2.4 hemophilia C
1.3 Market by Application
1.3.1 Global Hemophilia Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 AmbulatorySurgicalCenters
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Hemophilia Therapeutics Market Perspective (2016-2027)
2.2 Hemophilia Therapeutics Growth Trends by Regions
2.2.1 Hemophilia Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Hemophilia Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Hemophilia Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Hemophilia Therapeutics Industry Dynamic
2.3.1 Hemophilia Therapeutics Market Trends
2.3.2 Hemophilia Therapeutics Market Drivers
2.3.3 Hemophilia Therapeutics Market Challenges
2.3.4 Hemophilia Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Hemophilia Therapeutics Players by Revenue
3.1.1 Global Top Hemophilia Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Hemophilia Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Hemophilia Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Hemophilia Therapeutics Revenue
3.4 Global Hemophilia Therapeutics Market Concentration Ratio
3.4.1 Global Hemophilia Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hemophilia Therapeutics Revenue in 2020
3.5 Hemophilia Therapeutics Key Players Head office and Area Served
3.6 Key Players Hemophilia Therapeutics Product Solution and Service
3.7 Date of Enter into Hemophilia Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Hemophilia Therapeutics Breakdown Data by Type
4.1 Global Hemophilia Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Hemophilia Therapeutics Forecasted Market Size by Type (2022-2027)

5 Hemophilia Therapeutics Breakdown Data by Application
5.1 Global Hemophilia Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Hemophilia Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Hemophilia Therapeutics Market Size (2016-2027)
6.2 North America Hemophilia Therapeutics Market Size by Type
6.2.1 North America Hemophilia Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Hemophilia Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Hemophilia Therapeutics Market Size by Type (2016-2027)
6.3 North America Hemophilia Therapeutics Market Size by Application
6.3.1 North America Hemophilia Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Hemophilia Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Hemophilia Therapeutics Market Size by Application (2016-2027)
6.4 North America Hemophilia Therapeutics Market Size by Country
6.4.1 North America Hemophilia Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Hemophilia Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Hemophilia Therapeutics Market Size (2016-2027)
7.2 Europe Hemophilia Therapeutics Market Size by Type
7.2.1 Europe Hemophilia Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Hemophilia Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Hemophilia Therapeutics Market Size by Type (2016-2027)
7.3 Europe Hemophilia Therapeutics Market Size by Application
7.3.1 Europe Hemophilia Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Hemophilia Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Hemophilia Therapeutics Market Size by Application (2016-2027)
7.4 Europe Hemophilia Therapeutics Market Size by Country
7.4.1 Europe Hemophilia Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Hemophilia Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Hemophilia Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Hemophilia Therapeutics Market Size by Type
8.2.1 Asia-Pacific Hemophilia Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Hemophilia Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Hemophilia Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Hemophilia Therapeutics Market Size by Application
8.3.1 Asia-Pacific Hemophilia Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Hemophilia Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Hemophilia Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Hemophilia Therapeutics Market Size by Region
8.4.1 Asia-Pacific Hemophilia Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Hemophilia Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Hemophilia Therapeutics Market Size (2016-2027)
9.2 Latin America Hemophilia Therapeutics Market Size by Type
9.2.1 Latin America Hemophilia Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Hemophilia Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Hemophilia Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Hemophilia Therapeutics Market Size by Application
9.3.1 Latin America Hemophilia Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Hemophilia Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Hemophilia Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Hemophilia Therapeutics Market Size by Country
9.4.1 Latin America Hemophilia Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Hemophilia Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Hemophilia Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Hemophilia Therapeutics Market Size by Type
10.2.1 Middle East & Africa Hemophilia Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Hemophilia Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Hemophilia Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Hemophilia Therapeutics Market Size by Application
10.3.1 Middle East & Africa Hemophilia Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Hemophilia Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Hemophilia Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Hemophilia Therapeutics Market Size by Country
10.4.1 Middle East & Africa Hemophilia Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Hemophilia Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Bayer AG
11.1.1 Bayer AG Company Details
11.1.2 Bayer AG Business Overview
11.1.3 Bayer AG Hemophilia Therapeutics Introduction
11.1.4 Bayer AG Revenue in Hemophilia Therapeutics Business (2016-2021)
11.1.5 Bayer AG Recent Development
11.2 Pfizer, Inc.
11.2.1 Pfizer, Inc. Company Details
11.2.2 Pfizer, Inc. Business Overview
11.2.3 Pfizer, Inc. Hemophilia Therapeutics Introduction
11.2.4 Pfizer, Inc. Revenue in Hemophilia Therapeutics Business (2016-2021)
11.2.5 Pfizer, Inc. Recent Development
11.3 Novo Nordisk A/S
11.3.1 Novo Nordisk A/S Company Details
11.3.2 Novo Nordisk A/S Business Overview
11.3.3 Novo Nordisk A/S Hemophilia Therapeutics Introduction
11.3.4 Novo Nordisk A/S Revenue in Hemophilia Therapeutics Business (2016-2021)
11.3.5 Novo Nordisk A/S Recent Development
11.4 Baxter International Inc.
11.4.1 Baxter International Inc. Company Details
11.4.2 Baxter International Inc. Business Overview
11.4.3 Baxter International Inc. Hemophilia Therapeutics Introduction
11.4.4 Baxter International Inc. Revenue in Hemophilia Therapeutics Business (2016-2021)
11.4.5 Baxter International Inc. Recent Development
11.5 Biogen Idec, Inc.
11.5.1 Biogen Idec, Inc. Company Details
11.5.2 Biogen Idec, Inc. Business Overview
11.5.3 Biogen Idec, Inc. Hemophilia Therapeutics Introduction
11.5.4 Biogen Idec, Inc. Revenue in Hemophilia Therapeutics Business (2016-2021)
11.5.5 Biogen Idec, Inc. Recent Development
11.6 Genetics Institute
11.6.1 Genetics Institute Company Details
11.6.2 Genetics Institute Business Overview
11.6.3 Genetics Institute Hemophilia Therapeutics Introduction
11.6.4 Genetics Institute Revenue in Hemophilia Therapeutics Business (2016-2021)
11.6.5 Genetics Institute Recent Development
11.7 Alpha Therapeutics Corporation
11.7.1 Alpha Therapeutics Corporation Company Details
11.7.2 Alpha Therapeutics Corporation Business Overview
11.7.3 Alpha Therapeutics Corporation Hemophilia Therapeutics Introduction
11.7.4 Alpha Therapeutics Corporation Revenue in Hemophilia Therapeutics Business (2016-2021)
11.7.5 Alpha Therapeutics Corporation Recent Development
11.8 Expression Therapeutics
11.8.1 Expression Therapeutics Company Details
11.8.2 Expression Therapeutics Business Overview
11.8.3 Expression Therapeutics Hemophilia Therapeutics Introduction
11.8.4 Expression Therapeutics Revenue in Hemophilia Therapeutics Business (2016-2021)
11.8.5 Expression Therapeutics Recent Development
11.9 Swedish Orphan Biovitrum AB.
11.9.1 Swedish Orphan Biovitrum AB. Company Details
11.9.2 Swedish Orphan Biovitrum AB. Business Overview
11.9.3 Swedish Orphan Biovitrum AB. Hemophilia Therapeutics Introduction
11.9.4 Swedish Orphan Biovitrum AB. Revenue in Hemophilia Therapeutics Business (2016-2021)
11.9.5 Swedish Orphan Biovitrum AB. Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Hemophilia Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of hemophilia A
Table 3. Key Players of hemophilia B
Table 4. Key Players of hemophilia C
Table 5. Global Hemophilia Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Hemophilia Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Hemophilia Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Hemophilia Therapeutics Market Share by Regions (2016-2021)
Table 9. Global Hemophilia Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Hemophilia Therapeutics Market Share by Regions (2022-2027)
Table 11. Hemophilia Therapeutics Market Trends
Table 12. Hemophilia Therapeutics Market Drivers
Table 13. Hemophilia Therapeutics Market Challenges
Table 14. Hemophilia Therapeutics Market Restraints
Table 15. Global Hemophilia Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Hemophilia Therapeutics Market Share by Players (2016-2021)
Table 17. Global Top Hemophilia Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hemophilia Therapeutics as of 2020)
Table 18. Ranking of Global Top Hemophilia Therapeutics Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Hemophilia Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Hemophilia Therapeutics Product Solution and Service
Table 22. Date of Enter into Hemophilia Therapeutics Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Hemophilia Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Hemophilia Therapeutics Revenue Market Share by Type (2016-2021)
Table 26. Global Hemophilia Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Hemophilia Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Hemophilia Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Hemophilia Therapeutics Revenue Market Share by Application (2016-2021)
Table 30. Global Hemophilia Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Hemophilia Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Hemophilia Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Hemophilia Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Hemophilia Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Hemophilia Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Hemophilia Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Hemophilia Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Hemophilia Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Hemophilia Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Hemophilia Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Hemophilia Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Hemophilia Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Hemophilia Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Hemophilia Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Hemophilia Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Hemophilia Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Hemophilia Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Hemophilia Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Hemophilia Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Hemophilia Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Hemophilia Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Hemophilia Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Hemophilia Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Hemophilia Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Hemophilia Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Hemophilia Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Hemophilia Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Hemophilia Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Hemophilia Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Hemophilia Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Hemophilia Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 62. Bayer AG Company Details
Table 63. Bayer AG Business Overview
Table 64. Bayer AG Hemophilia Therapeutics Product
Table 65. Bayer AG Revenue in Hemophilia Therapeutics Business (2016-2021) & (US$ Million)
Table 66. Bayer AG Recent Development
Table 67. Pfizer, Inc. Company Details
Table 68. Pfizer, Inc. Business Overview
Table 69. Pfizer, Inc. Hemophilia Therapeutics Product
Table 70. Pfizer, Inc. Revenue in Hemophilia Therapeutics Business (2016-2021) & (US$ Million)
Table 71. Pfizer, Inc. Recent Development
Table 72. Novo Nordisk A/S Company Details
Table 73. Novo Nordisk A/S Business Overview
Table 74. Novo Nordisk A/S Hemophilia Therapeutics Product
Table 75. Novo Nordisk A/S Revenue in Hemophilia Therapeutics Business (2016-2021) & (US$ Million)
Table 76. Novo Nordisk A/S Recent Development
Table 77. Baxter International Inc. Company Details
Table 78. Baxter International Inc. Business Overview
Table 79. Baxter International Inc. Hemophilia Therapeutics Product
Table 80. Baxter International Inc. Revenue in Hemophilia Therapeutics Business (2016-2021) & (US$ Million)
Table 81. Baxter International Inc. Recent Development
Table 82. Biogen Idec, Inc. Company Details
Table 83. Biogen Idec, Inc. Business Overview
Table 84. Biogen Idec, Inc. Hemophilia Therapeutics Product
Table 85. Biogen Idec, Inc. Revenue in Hemophilia Therapeutics Business (2016-2021) & (US$ Million)
Table 86. Biogen Idec, Inc. Recent Development
Table 87. Genetics Institute Company Details
Table 88. Genetics Institute Business Overview
Table 89. Genetics Institute Hemophilia Therapeutics Product
Table 90. Genetics Institute Revenue in Hemophilia Therapeutics Business (2016-2021) & (US$ Million)
Table 91. Genetics Institute Recent Development
Table 92. Alpha Therapeutics Corporation Company Details
Table 93. Alpha Therapeutics Corporation Business Overview
Table 94. Alpha Therapeutics Corporation Hemophilia Therapeutics Product
Table 95. Alpha Therapeutics Corporation Revenue in Hemophilia Therapeutics Business (2016-2021) & (US$ Million)
Table 96. Alpha Therapeutics Corporation Recent Development
Table 97. Expression Therapeutics Company Details
Table 98. Expression Therapeutics Business Overview
Table 99. Expression Therapeutics Revenue in Hemophilia Therapeutics Business (2016-2021) & (US$ Million)
Table 100. Expression Therapeutics Recent Development
Table 101. Swedish Orphan Biovitrum AB. Company Details
Table 102. Swedish Orphan Biovitrum AB. Business Overview
Table 103. Swedish Orphan Biovitrum AB. Hemophilia Therapeutics Product
Table 104. Swedish Orphan Biovitrum AB. Revenue in Hemophilia Therapeutics Business (2016-2021) & (US$ Million)
Table 105. Swedish Orphan Biovitrum AB. Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hemophilia Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. hemophilia A Features
Figure 3. hemophilia B Features
Figure 4. hemophilia C Features
Figure 5. Global Hemophilia Therapeutics Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. AmbulatorySurgicalCenters Case Studies
Figure 9. Hemophilia Therapeutics Report Years Considered
Figure 10. Global Hemophilia Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Hemophilia Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Hemophilia Therapeutics Market Share by Regions: 2020 VS 2027
Figure 13. Global Hemophilia Therapeutics Market Share by Regions (2022-2027)
Figure 14. Global Hemophilia Therapeutics Market Share by Players in 2020
Figure 15. Global Top Hemophilia Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hemophilia Therapeutics as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Hemophilia Therapeutics Revenue in 2020
Figure 17. Global Hemophilia Therapeutics Revenue Market Share by Type (2016-2021)
Figure 18. Global Hemophilia Therapeutics Revenue Market Share by Type (2022-2027)
Figure 19. North America Hemophilia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Hemophilia Therapeutics Market Share by Type (2016-2027)
Figure 21. North America Hemophilia Therapeutics Market Share by Application (2016-2027)
Figure 22. North America Hemophilia Therapeutics Market Share by Country (2016-2027)
Figure 23. United States Hemophilia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Hemophilia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Hemophilia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Hemophilia Therapeutics Market Share by Type (2016-2027)
Figure 27. Europe Hemophilia Therapeutics Market Share by Application (2016-2027)
Figure 28. Europe Hemophilia Therapeutics Market Share by Country (2016-2027)
Figure 29. Germany Hemophilia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Hemophilia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Hemophilia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Hemophilia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Hemophilia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Hemophilia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Hemophilia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Hemophilia Therapeutics Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Hemophilia Therapeutics Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Hemophilia Therapeutics Market Share by Region (2016-2027)
Figure 39. China Hemophilia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Hemophilia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Hemophilia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Hemophilia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Hemophilia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Hemophilia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Hemophilia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Hemophilia Therapeutics Market Share by Type (2016-2027)
Figure 47. Latin America Hemophilia Therapeutics Market Share by Application (2016-2027)
Figure 48. Latin America Hemophilia Therapeutics Market Share by Country (2016-2027)
Figure 49. Mexico Hemophilia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Hemophilia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Hemophilia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Hemophilia Therapeutics Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Hemophilia Therapeutics Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Hemophilia Therapeutics Market Share by Country (2016-2027)
Figure 55. Turkey Hemophilia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Hemophilia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Hemophilia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Bayer AG Revenue Growth Rate in Hemophilia Therapeutics Business (2016-2021)
Figure 59. Pfizer, Inc. Revenue Growth Rate in Hemophilia Therapeutics Business (2016-2021)
Figure 60. Novo Nordisk A/S Revenue Growth Rate in Hemophilia Therapeutics Business (2016-2021)
Figure 61. Baxter International Inc. Revenue Growth Rate in Hemophilia Therapeutics Business (2016-2021)
Figure 62. Biogen Idec, Inc. Revenue Growth Rate in Hemophilia Therapeutics Business (2016-2021)
Figure 63. Genetics Institute Revenue Growth Rate in Hemophilia Therapeutics Business (2016-2021)
Figure 64. Alpha Therapeutics Corporation Revenue Growth Rate in Hemophilia Therapeutics Business (2016-2021)
Figure 65. Expression Therapeutics Revenue Growth Rate in Hemophilia Therapeutics Business (2016-2021)
Figure 66. Swedish Orphan Biovitrum AB. Revenue Growth Rate in Hemophilia Therapeutics Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed

---